Welcome
Clinical Division
Research Division
Online Books
 Children's Diabetes Foundation
Meetings
UCHSC&Disclaimers
LineDown
BDC Home Page
Clinical Division
Clinical Division Introduction
Pediatric Clinic
Young Adult Clinic
Ophthalmology Clinic
Clinical Division Faculty
Clinical Research
HIPAA
Clinical Resources
Other Clinical Sites
Clinical Division Home

Clinical Research Trials

The Barbara Davis Center for Childhood Diabetes, located at the University of Colorado Health Sciences Center, is actively involved in clinical research. The research division has several on-going studies, as well as ones that are open for enrollment. These studies are all dedicated to the pursuit of preventing diabetes in high risk patients as well as clinical intervention with those already diagnosed with Type 1 diabetes. 

The following studies are currently enrolling eligible participants.  Please click on the study title for more specific information about the study and eligibility requirements.

Study Title Looking for...

TrialNet: Natural History Study of the Development of Type 1 Diabetes

Relatives of people with type 1 diabetes, 1st degree blood relatives ages 1-45 and 2nd degree relatives ages 1-20.
TrialNet: Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes

Previously screened in the Natural History Trial, and identified high-risk for the development of Type 1 diabetes.
AbATE Type 1 Diabetes Trial for New Onset Diabetes

Type 1 diabetes diagnosis within last 6 weeks.  Ages 8-30.
Phase I Study of BHT-3021 in Subjects with Type 1 Diabetes

Type 1 diabetes diagnosis. Ages 18 years and above, detectable C-peptide levels.
TolerX Type 1 Diabetes Trial

Type 1 diabetes diagnosis, ages 18-60, detectable C-peptide.
Effect of Antithymocyte Globulin (ATG) on Preserving Beta-Cell Function in New Onset Type 1 Diabetes Mellitus 18-35 years old.

TEDDY (The Environmental Determinants of Diabetes in the Young)

 Newborns with no family history of Type 1 diabetes.
Young siblings and offspring of persons with type 1 diabetes
Randomized Study of Real-Time Continuous Glucose Monitors in the Management of Type 1 Diabetes Clinical diagnosis of type 1 diabetes and using daily insulin therapy for at least one year.
Age >8 years.
HbA1c less than or equal to 10.0%

Understanding Diabetes - new! 11th Edition
by Dr. H. Peter Chase, MD

Type 1 Diabetes: Cellular, Molecular & Clinical Immunology
edited by George S. Eisenbarth & Kevin Lafferty
Updated chapters and teaching slides online

Please click here for a list of Clinical Division members.

Please click here for a list of Research Division members.